These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 21938406

  • 1. Subcellular basis of vitamin C protection against doxorubicin-induced changes in rat cardiomyocytes.
    Ludke A, Sharma AK, Bagchi AK, Singal PK.
    Mol Cell Biochem; 2012 Jan; 360(1-2):215-24. PubMed ID: 21938406
    [Abstract] [Full Text] [Related]

  • 2. Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C.
    Ludke A, Akolkar G, Ayyappan P, Sharma AK, Singal PK.
    PLoS One; 2017 Jan; 12(7):e0179452. PubMed ID: 28678856
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mechanistic clues to the protective effect of chrysin against doxorubicin-induced cardiomyopathy: Plausible roles of p53, MAPK and AKT pathways.
    Mantawy EM, Esmat A, El-Bakly WM, Salah ElDin RA, El-Demerdash E.
    Sci Rep; 2017 Jul 06; 7(1):4795. PubMed ID: 28684738
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Chitosan oligosaccharides prevent doxorubicin-induced oxidative stress and cardiac apoptosis through activating p38 and JNK MAPK mediated Nrf2/ARE pathway.
    Zhang Y, Ahmad KA, Khan FU, Yan S, Ihsan AU, Ding Q.
    Chem Biol Interact; 2019 May 25; 305():54-65. PubMed ID: 30928397
    [Abstract] [Full Text] [Related]

  • 9. Doxorubicin-induced nitrosative stress is mitigated by vitamin C via the modulation of nitric oxide synthases.
    Akolkar G, Bagchi AK, Ayyappan P, Jassal DS, Singal PK.
    Am J Physiol Cell Physiol; 2017 Apr 01; 312(4):C418-C427. PubMed ID: 28100487
    [Abstract] [Full Text] [Related]

  • 10. Sirt6 protects cardiomyocytes against doxorubicin-induced cardiotoxicity by inhibiting P53/Fas-dependent cell death and augmenting endogenous antioxidant defense mechanisms.
    Wu S, Lan J, Li L, Wang X, Tong M, Fu L, Zhang Y, Xu J, Chen X, Chen H, Li R, Wu Y, Xin J, Yan X, Li H, Xue K, Li X, Zhuo C, Jiang W.
    Cell Biol Toxicol; 2023 Feb 01; 39(1):237-258. PubMed ID: 34713381
    [Abstract] [Full Text] [Related]

  • 11. Evidences for the mechanism of Shenmai injection antagonizing doxorubicin-induced cardiotoxicity.
    Wu YP, Zhang S, Xin YF, Gu LQ, Xu XZ, Zhang CD, You ZQ.
    Phytomedicine; 2021 Jul 15; 88():153597. PubMed ID: 34111614
    [Abstract] [Full Text] [Related]

  • 12. Davallialactone protects against adriamycin-induced cardiotoxicity in vitro and in vivo.
    Arunachalam S, Kim SY, Lee SH, Lee YH, Kim MS, Yun BS, Yi HK, Hwang PH.
    J Nat Med; 2012 Jan 15; 66(1):149-57. PubMed ID: 21858697
    [Abstract] [Full Text] [Related]

  • 13. Astragaloside IV inhibits doxorubicin-induced cardiomyocyte apoptosis mediated by mitochondrial apoptotic pathway via activating the PI3K/Akt pathway.
    Jia Y, Zuo D, Li Z, Liu H, Dai Z, Cai J, Pang L, Wu Y.
    Chem Pharm Bull (Tokyo); 2014 Jan 15; 62(1):45-53. PubMed ID: 24390491
    [Abstract] [Full Text] [Related]

  • 14. The protective role of arjunolic acid against doxorubicin induced intracellular ROS dependent JNK-p38 and p53-mediated cardiac apoptosis.
    Ghosh J, Das J, Manna P, Sil PC.
    Biomaterials; 2011 Jul 15; 32(21):4857-66. PubMed ID: 21486680
    [Abstract] [Full Text] [Related]

  • 15. Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway.
    Kim KH, Oudit GY, Backx PH.
    J Pharmacol Exp Ther; 2008 Jan 15; 324(1):160-9. PubMed ID: 17928571
    [Abstract] [Full Text] [Related]

  • 16. WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death.
    Venkatesan B, Prabhu SD, Venkatachalam K, Mummidi S, Valente AJ, Clark RA, Delafontaine P, Chandrasekar B.
    Cell Signal; 2010 May 15; 22(5):809-20. PubMed ID: 20074638
    [Abstract] [Full Text] [Related]

  • 17. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
    Zhao D, Xue C, Li J, Feng K, Zeng P, Chen Y, Duan Y, Zhang S, Li X, Han J, Yang X.
    Biochem Biophys Res Commun; 2020 Dec 10; 533(3):304-312. PubMed ID: 32958254
    [Abstract] [Full Text] [Related]

  • 18. Neuregulin-1 attenuates doxorubicin-induced autophagy in neonatal rat cardiomyocytes.
    An T, Huang Y, Zhou Q, Wei BQ, Zhang RC, Yin SJ, Zou CH, Zhang YH, Zhang J.
    J Cardiovasc Pharmacol; 2013 Aug 10; 62(2):130-7. PubMed ID: 23519142
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.